Ramucirumab [ramucirumab]

topical
1
Terms

Cyramza

 

1121B
Cyramza
IMC 1121B
IMC-1121B
IMC1121B
LY3009806

Persistent link   https://www.medvik.cz/link/D000096662
Definition

A humanized monoclonal antibody and antagonist of VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2).

DUI
D000096662 MeSH Browser
CUI
M000762505
History note
2024 (2009)
Public note
2024; RAMUCIRUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2009-2023

Allowable subheadings

AD
administration & dosage
AE
adverse effects
AG
agonists
AA
analogs & derivatives
AN
analysis
AI
antagonists & inhibitors
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology 1
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 1
TO
toxicity
UR
urine

D Chemicals and Drugs
D12 Amino Acids, Peptides, and Proteins 16
D12.776 Proteins 2 577
D12.776.124 Blood Proteins 909
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 489
D12.776.124.486.485.114 Antibodies 1 815
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 629
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 790
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 347
D12.776.124.486.485.114.224.060.313 Alemtuzumab 123
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 445
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 40
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 47
D12.776.124.486.485.114.224.060.750 Cetuximab 185
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 150
D12.776.124.486.485.114.224.060.790 Gemtuzumab 16
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.486.485.114.224.060.798 Ipilimumab 253
D12.776.124.486.485.114.224.060.813 Natalizumab 156
D12.776.124.486.485.114.224.060.829 Nivolumab 432
D12.776.124.486.485.114.224.060.844 Omalizumab 112
D12.776.124.486.485.114.224.060.860 Palivizumab 12
D12.776.124.486.485.114.224.060.864 Panitumumab 57
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 61
D12.776.124.486.485.114.224.060.875 Trastuzumab 269
D12.776.124.486.485.114.224.060.937 Ustekinumab 121
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 489
D12.776.124.790.651.114 Antibodies 1 815
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 629
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 790
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 347
D12.776.124.790.651.114.224.060.375 Alemtuzumab 123
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 445
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 40
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 47
D12.776.124.790.651.114.224.060.750 Cetuximab 185
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 150
D12.776.124.790.651.114.224.060.790 Gemtuzumab 16
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.790.651.114.224.060.798 Ipilimumab 253
D12.776.124.790.651.114.224.060.813 Natalizumab 156
D12.776.124.790.651.114.224.060.829 Nivolumab 432
D12.776.124.790.651.114.224.060.844 Omalizumab 112
D12.776.124.790.651.114.224.060.860 Palivizumab 12
D12.776.124.790.651.114.224.060.864 Panitumumab 57
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 61
D12.776.124.790.651.114.224.060.875 Trastuzumab 269
D12.776.124.790.651.114.224.060.937 Ustekinumab 121
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 489
D12.776.377.715.548.114 Antibodies 1 815
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 629
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 790
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 347
D12.776.377.715.548.114.224.200.375 Alemtuzumab 123
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 445
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 40
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 47
D12.776.377.715.548.114.224.200.750 Cetuximab 185
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 150
D12.776.377.715.548.114.224.200.790 Gemtuzumab 16
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 12
D12.776.377.715.548.114.224.200.798 Ipilimumab 253
D12.776.377.715.548.114.224.200.813 Natalizumab 156
D12.776.377.715.548.114.224.200.829 Nivolumab 432
D12.776.377.715.548.114.224.200.844 Omalizumab 112
D12.776.377.715.548.114.224.200.860 Palivizumab 12
D12.776.377.715.548.114.224.200.864 Panitumumab 57
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 61
D12.776.377.715.548.114.224.200.875 Trastuzumab 269
D12.776.377.715.548.114.224.200.937 Ustekinumab 121

Add